Edward Stepanski

3.6k total citations
48 papers, 2.4k citations indexed

About

Edward Stepanski is a scholar working on Experimental and Cognitive Psychology, Cognitive Neuroscience and Oncology. According to data from OpenAlex, Edward Stepanski has authored 48 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Experimental and Cognitive Psychology, 20 papers in Cognitive Neuroscience and 8 papers in Oncology. Recurrent topics in Edward Stepanski's work include Sleep and related disorders (21 papers), Sleep and Wakefulness Research (20 papers) and Medication Adherence and Compliance (6 papers). Edward Stepanski is often cited by papers focused on Sleep and related disorders (21 papers), Sleep and Wakefulness Research (20 papers) and Medication Adherence and Compliance (6 papers). Edward Stepanski collaborates with scholars based in United States, United Kingdom and Türkiye. Edward Stepanski's co-authors include James K. Wyatt, Thomas Roth, Frank Zorick, Michael L. Perlis, Ali Keshavarzian, Ziba Ranjbaran, Laurie Keefer, Pietro Badia, James Lamphere and H. Heith Durrence and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Psychiatry and Clinical Cancer Research.

In The Last Decade

Edward Stepanski

42 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edward Stepanski United States 21 1.4k 1.0k 575 417 272 48 2.4k
Mairav Cohen‐Zion United States 20 1.3k 0.9× 881 0.9× 591 1.0× 506 1.2× 176 0.6× 29 2.6k
Kathy P. Parker United States 22 997 0.7× 575 0.6× 325 0.6× 270 0.6× 301 1.1× 34 1.8k
Charles Samuels Canada 20 1.1k 0.8× 632 0.6× 215 0.4× 280 0.7× 168 0.6× 35 1.8k
Habibolah Khazaie Iran 28 1.3k 0.9× 1.1k 1.1× 555 1.0× 693 1.7× 53 0.2× 153 3.1k
Valerie McLaughlin Crabtree United States 28 1.0k 0.7× 770 0.8× 642 1.1× 646 1.5× 73 0.3× 73 2.3k
Ferdinand Zizi United States 30 1.5k 1.1× 799 0.8× 741 1.3× 859 2.1× 36 0.1× 84 2.8k
Sarosh J. Motivala United States 23 1.1k 0.8× 531 0.5× 347 0.6× 256 0.6× 57 0.2× 34 2.3k
Stephen Johnson United States 16 1.4k 1.0× 1.3k 1.2× 764 1.3× 634 1.5× 32 0.1× 23 2.4k
Megan Crawford United States 27 588 0.4× 756 0.7× 423 0.7× 524 1.3× 42 0.2× 64 2.3k
Monica Martoni Italy 23 1.2k 0.9× 688 0.7× 426 0.7× 220 0.5× 75 0.3× 80 1.8k

Countries citing papers authored by Edward Stepanski

Since Specialization
Citations

This map shows the geographic impact of Edward Stepanski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Stepanski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Stepanski more than expected).

Fields of papers citing papers by Edward Stepanski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward Stepanski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Stepanski. The network helps show where Edward Stepanski may publish in the future.

Co-authorship network of co-authors of Edward Stepanski

This figure shows the co-authorship network connecting the top 25 collaborators of Edward Stepanski. A scholar is included among the top collaborators of Edward Stepanski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward Stepanski. Edward Stepanski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Xin, Janeane N. Anderson, Gregory A. Vidal, et al.. (2025). Perceived discrimination, patient-provider communication, and quality of life among breast cancer survivors: a mediation analysis. Journal of Cancer Survivorship.
2.
Hu, Xin, Cameron M. Kaplan, Michelle Y. Martin, et al.. (2022). Race Differences in Patient-Reported Symptoms during Chemotherapy among Women with Early-Stage Hormone Receptor–Positive Breast Cancer. Cancer Epidemiology Biomarkers & Prevention. 32(2). 167–174. 6 indexed citations
3.
Harvey, R. Donald, Suanna S. Bruinooge, Li Chen, et al.. (2021). Impact of Broadening Trial Eligibility Criteria for Patients with Advanced Non–Small Cell Lung Cancer: Real-World Analysis of Select ASCO- Friends Recommendations. Clinical Cancer Research. 27(9). 2430–2434. 29 indexed citations
4.
Hu, Xin, Cameron M. Kaplan, Rebecca A. Krukowski, et al.. (2021). Characterization of Clinical Symptoms by Race Among Women With Early-Stage, Hormone Receptor–Positive Breast Cancer Before Starting Chemotherapy. JAMA Network Open. 4(6). e2112076–e2112076. 11 indexed citations
5.
Agrawal, Smita, Ping Sun, Claudia Cabrera, et al.. (2020). Machine learning imputation of Eastern Cooperative Oncology Group performance status (ECOG PS) scores from data in CancerLinQ discovery.. Journal of Clinical Oncology. 38(15_suppl). e19318–e19318. 6 indexed citations
6.
7.
Graetz, Ilana, et al.. (2017). Use of a web-based app to improve breast cancer symptom management and aromatase inhibitor adherence.. Journal of Clinical Oncology. 35(5_suppl). 89–89. 1 indexed citations
8.
Harrison, Michael R., Bradford R. Hirsch, Daniel J. George, et al.. (2014). Real-World Outcomes in Metastatic Renal Cell Carcinoma: Insights From a Joint Community-Academic Registry. Journal of Oncology Practice. 10(2). e63–e72. 26 indexed citations
9.
Stepanski, Edward, Arthur C. Houts, Lee S. Schwartzberg, et al.. (2009). Second- and Third-line Treatment of Patients With Non–Small-Cell Lung Cancer With Erlotinib in the Community Setting: Retrospective Study of Patient Healthcare Utilization and Symptom Burden. Clinical Lung Cancer. 10(6). 426–432. 6 indexed citations
10.
Schwartzberg, Lee S., Patrick Cobb, Frank M. Senecal, et al.. (2009). Initial treatment and changes in adjuvant endocrine therapy for early stage breast cancer. The Breast. 18(2). 78–83. 12 indexed citations
11.
Stepanski, Edward, et al.. (2006). Recent Developments in the Classification, Evaluation, and Treatment of Insomnia. CHEST Journal. 130(1). 276–286. 56 indexed citations
12.
Wyatt, James K., et al.. (2006). Circadian Phase in Delayed Sleep Phase Syndrome: Predictors and Temporal Stability Across Multiple Assessments. SLEEP. 29(8). 1075–1080. 53 indexed citations
13.
Stepanski, Edward. (2005). Hypnotics should not be considered for the initial treatment of chronic insomnia. Con.. PubMed. 1(2). 125–8. 15 indexed citations
14.
Stepanski, Edward & James K. Wyatt. (2003). Use of sleep hygiene in the treatment of insomnia. Sleep Medicine Reviews. 7(3). 215–225. 484 indexed citations
15.
Stepanski, Edward. (2003). Behavioral Sleep Medicine: A Historical Perspective. Behavioral Sleep Medicine. 1(1). 4–21. 12 indexed citations
16.
Stepanski, Edward & Michael L. Perlis. (2000). Behavioral sleep medicine. Journal of Psychosomatic Research. 49(5). 343–347. 135 indexed citations
17.
Buysse, Daniel J., Charles F. Reynolds, David J. Kupfer, et al.. (1997). Effects of Diagnosis on Treatment Recommendations in Chronic Insomnia—A Report from the APA/NIMH DSM-IV Field Trial. SLEEP. 20(7). 542–552. 31 indexed citations
18.
Stepanski, Edward, et al.. (1990). Psychometric profiles of patient populations with excessive daytime sleepiness.. PubMed. 38(4). 219–22. 2 indexed citations
19.
Roth, Thomas, Timothy Roehrs, Ardith Zwyghuizen‐Doorenbos, Edward Stepanski, & Robert M. Wittig. (1988). Sleep and Memory. PubMed. 6. 140–145. 5 indexed citations
20.
Röth, Thomas, Frank Zorick, J. Sicklesteel, & Edward Stepanski. (1981). Effects of benzodiazepines on sleep and wakefulness.. British Journal of Clinical Pharmacology. 11(S1). 31S–35S. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mairav Cohen‐Zion Breakdown of academic impact, for papers by Kathy P. Parker Breakdown of academic impact, for papers by Charles Samuels Breakdown of academic impact, for papers by Habibolah Khazaie Breakdown of academic impact, for papers by Valerie McLaughlin Crabtree Breakdown of academic impact, for papers by Ferdinand Zizi Breakdown of academic impact, for papers by Sarosh J. Motivala Breakdown of academic impact, for papers by Stephen Johnson Breakdown of academic impact, for papers by Megan Crawford Breakdown of academic impact, for papers by Monica Martoni
Rankless by CCL
2026